HCR Wealth Advisors
Position in NTHI — Neonc Technologies Holdings, Inc.
CIK 1697715
LOS ANGELES, CA
Position in NTHI
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$67,950
-$37,200 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 20 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTHI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HCR Wealth Advisors holds $346,101 across 2 Biotechnology names. NTHI ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924 | $278,151 | |
| 2 | NTHI |
Neonc Technologies Holdings, Inc.
This page
|
15,000 | $67,950 |
All Filings in NTHI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,950 | 15,000 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $105,150 | 15,000 | Shares | Sole | 2026-04-21 | |
| 2025-09-30 | $136,200 | 15,000 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $53,550 | 15,000 | Shares | Sole | 2025-07-17 | |
| No filing history on record for this holder in this stock. | ||||||